The Need For Biomarkers To Aid In Treatment Decision Making For Upper Tract Urothelial Carcinoma

The need for biomarkers to aid in treatment decision making for upper tract urothelial carcinoma

Unmet needs for patients with upper tract urothelial carcinoma

Recent advances in the treatment of upper tract urothelial carcinoma

An AI biomarker to aid in the decision of treatment with ADT for localized prostate cancer

Urologic Treatments of Upper Tract Urothelial Carcinoma

Bladder Cancer Advocacy Network

Upper Tract Urothelial Cancer: Challenges and Opportunities for Treating the Unmet Medical Need

Grand Rounds in Urology

Oncologic Treatment of Upper Tract Urothelial Carcinoma

Bladder Cancer Advocacy Network

Tumor centric- and liquid biomarkers for guiding treatment decisions in bladder cancer

Queen's Health Sciences

Molecular markers guiding treatment approaches in bladder cancer

Biomarkers for novel RCC and urothelial carcinoma treatments

Robotic surgery for patients with upper tract urothelial carcinoma

Neoadjuvant chemotherapy in patients with high-grade upper tract urothelial carcinoma

Future roles for liquid biopsies in clinical decision making in uro-oncology

European School of Urology

Advances in Treating Upper Tract Urothelial Cancer

Grand Rounds in Urology

What are the latest biomarkers for urothelial carcinoma?

Contemporary Management of Upper Tract Urothelial Carcinoma

Grand Rounds in Urology

The role of molecular biomarkers in determining patient response to bladder cancer treatment

DNA methylation urine biomarkers test ( Epicheck® assay) in the diagnosis of UTUC.

Current obstacles in the treatment of urothelial carcinoma

Advanced upper urinary tract urothelial carcinoma: treatment landscape and remaining challenges